Danny Griffin

Danny Griffin currently serves as the Director of Business Development at Bond Biosciences and as Acting Chief Scientific Officer at Kinimmune, Inc., both since February 2022. Additionally, Danny holds a VC Fellow position at BioGenerator Ventures. Previous experience includes a PhRMA Foundation Postdoctoral Researcher role at The University of Kansas, where work focused on protein production and high throughput sequencing, and participation in projects related to immunotherapy efficacy. Danny's academic background includes a Ph.D. in Bioengineering from The University of Kansas and a Bachelor's Degree in Biomedical Engineering from Widener University. Relevant research experience also involves a Visiting Predoctoral Researcher role at the National Institutes of Health and an Undergraduate Research Assistant position at Widener University.